Ramsauer, K; Reisinger, E; Firbas, C; Wiedermann-Schmidt, U; Beubler, E; Pfeiffer, A; Mullner, M; Aberle, J; Tauber, E.
Phase 2 clinical results: Chikungunya vaccine based on measles vector (MV-CHIK) induces humoral and cellular responses in the presence of pre-existing anti measles immunity
INT J INFECT DIS. 2019; 79: 118-118.
Doi: 10.1016/j.ijid.2018.11.291
[Poster]
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG